Cargando…
KRAS Pathway Alterations in Malignant Pleural Mesothelioma: An Underestimated Player
SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is a rare, incurable cancer. KRAS pathway alterations are frequent in human MPM but have been likely underestimated by next generation sequencing studies. ABSTRACT: Malignant pleural mesothelioma (MPM) is a rare, incurable cancer of the mesothelia...
Autores principales: | Trassl, Lilith, Stathopoulos, Georgios T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454618/ https://www.ncbi.nlm.nih.gov/pubmed/36077838 http://dx.doi.org/10.3390/cancers14174303 |
Ejemplares similares
-
KRAS signaling in malignant pleural mesothelioma
por: Marazioti, Antonia, et al.
Publicado: (2021) -
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
por: Urso, Loredana, et al.
Publicado: (2019) -
Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018) -
KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma
por: Vannucchi, Margherita, et al.
Publicado: (2023) -
Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)